Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
07/11/2012 | CN101829186B Solid dispersant for improving dissolution of Tibet medicinal halenia extract |
07/11/2012 | CN101829050B Natural brain protein hydrolysate injection and preparation method thereof |
07/11/2012 | CN101801342B Methods for producing aripiprazole suspension and freeze-dried formulation |
07/11/2012 | CN101791295B Compound monoammonium glycyrrhizinate S pharmaceutical composition and method for preparing frozen powder injection |
07/11/2012 | CN101773471B Mitoxantrone targeting sustained-release long-circulating nanometer liposome and preparation method |
07/11/2012 | CN101757407B Traditional Chinese medicine composition for treating asthma and preparation method thereof |
07/11/2012 | CN101757200B Traditional Chinese medicine composition for treating chronic gastritis and preparation method thereof |
07/11/2012 | CN101703776B Method for preparing anti-infective agent long-acting injection |
07/11/2012 | CN101703763B Production method of human fibrinogen |
07/11/2012 | CN101703473B Polylactic acid-glycollic acid copolymer microspheres and preparation method |
07/11/2012 | CN101637481B Prescription of gingkgo leaf soft capsule and preparation method thereof |
07/11/2012 | CN101618126B Analgesic antiphlogistic gel and preparation method thereof |
07/11/2012 | CN101596165B Pantoprazole sodium enteric-coated pellet |
07/11/2012 | CN101574387B Quality control method for stringy stonecrop herb preparation |
07/11/2012 | CN101563107B Radioactive diagnostic imaging agent |
07/11/2012 | CN101563069B Multilayer orally disintegrating tablet |
07/11/2012 | CN101507785B Ointment for treating psoriasis |
07/11/2012 | CN101411851B Chinese medicinal composition for preventing and treating hyperlipemia symptom and atherosclerosis |
07/11/2012 | CN101411694B Patch preparation |
07/11/2012 | CN101400340B Improved process for producing a solid dispersion of an active ingredient |
07/11/2012 | CN101288641B Coenzyme Q10 water dispersion and preparation method thereof |
07/11/2012 | CN101279001B Preparation method of pummelo peel extract |
07/11/2012 | CN101217945B Oral drug compliance monitoring using radio frequency identification tags |
07/11/2012 | CN101056617B In-situ forming implant for animals |
07/11/2012 | CA2727477A1 Stable ready to use injectable paracetamol formulation |
07/10/2012 | US8219982 Method for organizing the software of a fluid management system |
07/10/2012 | US8219171 Delivery device for implantable monitor |
07/10/2012 | US8219168 Article and method for applying a coupling agent for a non-invasive optical probe |
07/10/2012 | US8217665 Radio-frequency ion channel probe |
07/10/2012 | US8217080 Anti-infective methods and systems for treating pathogen-induced disordered tissues |
07/10/2012 | US8216776 Dialysate of peritoneal dialysis and its preparation method |
07/10/2012 | US8216613 Drugs embedded in anionic acrylic acid-methacryilc acid copolymers; extrusion |
07/10/2012 | US8216612 Embolization |
07/10/2012 | US8216611 Combined-step process for pharmaceutical compositions |
07/10/2012 | US8216610 Oral paracetamol formulations |
07/10/2012 | US8216609 Release dosage form comprising of a high solubility active ingredient, which utilizes dual retard technique to effectively reduce the quantity of release controlling agents; a process for preparing the dosage form. |
07/10/2012 | US8216608 Gastric antacid |
07/10/2012 | US8216607 Combination of ceramide and gemcitabine for inducing cell death and uses thereof in treating cancer |
07/10/2012 | US8216606 Dermal composition for controlling drug flux comprising two acrylic adhesive polymers having different functionalities and different solubility parameters |
07/10/2012 | US8216604 Intranasally administering aqueous solution offentanyl or salt thereof and pectin |
07/10/2012 | US8216597 Oil-in-water emulsion composition and method for producing the same |
07/10/2012 | US8216591 With collagen and a polysaccharide such as hydroxyethyl starch as stabilizer; reduced toxicity and/or a reduced immunogenicity |
07/10/2012 | US8216583 Formulation of human antibodies for treating TNF-α associated disorders |
07/10/2012 | US8216561 Polyacrylamide hydrogel for the treatment of incontinence and vesicouretal reflex |
07/10/2012 | US8216560 Administering a potassium-binding polymer of a crosslinked ion exchange polymer having acid groups and an alpha/beta electronegative group in a bead form as an oral dosage; renal insufficiency; congestive heart failure; hyperkalemia; high preferential binding capaciity; stability; nonabsorbent; nontoxic |
07/10/2012 | US8216177 Implantable drug delivery systems and methods |
07/10/2012 | DE202012002838U1 Zahnpflegender Kaugummi mit Naturstoffen zur Rauchentwöhnung Dental nurses chewing gum with natural substances for smoking cessation |
07/10/2012 | CA2601955C Pharmaceutical composition comprising an omega-carboxyaryl substituted diphenyl urea for the treatment of cancer |
07/10/2012 | CA2545139C Low-dose tablets having a network of polymers |
07/10/2012 | CA2543857C Self-supporting films for pharmaceutical and food use |
07/10/2012 | CA2535593C Concentrated and diluted stable oil/water emulsions |
07/10/2012 | CA2531150C Palatable ductile chewable veterinary composition |
07/10/2012 | CA2506034C Solid mucoadhesive composition |
07/10/2012 | CA2500390C Compositions having an inner core and at least two surrounding layers |
07/10/2012 | CA2500387C A controlled release system containing temozolomide |
07/10/2012 | CA2499994C Abuse-resistant pharmaceutical compositions |
07/10/2012 | CA2494915C Female hormone-containing patch |
07/10/2012 | CA2489395C Filters for combined radiotelephone/gps terminals |
07/10/2012 | CA2485253C Lipid a and other carbohydrate ligand analogs |
07/10/2012 | CA2483218C Particulate materials |
07/10/2012 | CA2479652C Crystalline micronisate of tiotropium bromide |
07/10/2012 | CA2470207C Matrix film tablet with controlled release of natural mixtures of conjugated estrogens |
07/10/2012 | CA2466529C Solid, stabilized, prompt- and/or modified-release therapeutical systems for the oral administration of liquid active principles, excipients or foodstuffs |
07/10/2012 | CA2440010C Powder inhaler formulations |
07/10/2012 | CA2429543C Method for obtaining antigenic aggregates and the use thereof in formulations |
07/10/2012 | CA2319327C Sterile complex of therapeutic peptide bond to a polysaccharide |
07/10/2012 | CA2246501C Stabilised growth hormone formulation and method of preparation thereof |
07/10/2012 | CA2210992C Mixture of fatty acids, derivatives and a compound of vegetal origin having attractive effect on cats |
07/06/2012 | CA2819663A1 Rapidly dispersing granules, orally disintegrating tablets and methods |
07/06/2012 | CA2775393A1 Topical non-aqueous pharmaceutical formulations |
07/05/2012 | WO2012092628A2 Patches and methods for the transdermal delivery of agents to treat hair loss |
07/05/2012 | WO2012092594A2 Preparations for topical prevention and/or treatment of oral allergic symptoms due to oral contact with fruits and/or vegetables |
07/05/2012 | WO2012092510A2 Ocular drug delivery system |
07/05/2012 | WO2012092504A2 Nanoparticle and surface-modified particulate coatings, coated balloons, and methods therefore |
07/05/2012 | WO2012092490A1 Diagnosis of prostate cancer |
07/05/2012 | WO2012092486A2 Modified release benzimidazole formulations |
07/05/2012 | WO2012092420A2 Methods for cryopreserving and encapsulating cells |
07/05/2012 | WO2012092305A2 Nanonized iron compositions and methods of use thereof |
07/05/2012 | WO2012092283A1 Drug delivery dispersion and film formed therefrom |
07/05/2012 | WO2012092165A1 Transdermal drug delivery system comprising levonorgestrel acetate |
07/05/2012 | WO2012091823A1 Use of glutamide stabilizers |
07/05/2012 | WO2012091748A2 Therapeutic agent reservoir delivery system |
07/05/2012 | WO2012091680A1 A device for controlled release of a bioactive agent |
07/05/2012 | WO2012091593A1 Granulates comprising eslicarbazepine acetate |
07/05/2012 | WO2012091523A2 Carrier for negatively charged drugs comprising a cationic lipid and a preparation method thereof |
07/05/2012 | WO2012091518A2 Phospholipid nanoparticles for mr-induced high-intensity focused ultrasonic treatment and diagnosis, and method for producing same |
07/05/2012 | WO2012091372A2 Caffeine tape for body slimming |
07/05/2012 | WO2012091153A2 Orally disintegrating tablet |
07/05/2012 | WO2012091137A1 GENE THERAPEUTIC AGENT USING TNF-α, CD40L, AND GM-CSF IN COMBINATION |
07/05/2012 | WO2012091054A1 Liposome composition and process for production thereof |
07/05/2012 | WO2012091049A1 Orally disintegrating tablet |
07/05/2012 | WO2012091040A1 Decay-type nuclear particle for pharmaceutical formulation |
07/05/2012 | WO2012091039A1 Particulate formulation |
07/05/2012 | WO2012090994A1 Ophthalmic solution containing diquafosol, method for producing same, and method for preventing formation of insoluble precipitate |
07/05/2012 | WO2012090985A1 Aqueous ophthalmic composition |
07/05/2012 | WO2012090623A1 Capsule for delivering bifidobacterium into large intestine and method for producing same |
07/05/2012 | WO2012090322A1 Patch |
07/05/2012 | WO2012090223A1 Poly(ether imine) dendrimers and uses thereof |
07/05/2012 | WO2012090070A2 Biodegradable drug delivery compositions |
07/05/2012 | WO2012089933A2 Sachet of algae and/or clays with heatable hydrating support for medical or cosmetic care use |